From neuroinflammation to immune reprogramming: Nanozyme-Integrated nanoplatforms for neuroimmune modulation in Parkinson's disease
Parkinson's disease (PD) is a progressive neuroimmune disorder in which dysregulated neuron–glia–immune crosstalk drives chronic neuroinflammation, α-synuclein pathology, blood–brain barrier dysfunction, and mitochondrial failure, establishing interconnected neuroimmune pathways as therapeutic targets. Aberrant neuron–...